nodes	percent_of_prediction	percent_of_DWPC	metapath
Nandrolone decanoate—MAOB—Zonisamide—epilepsy syndrome	0.299	0.56	CbGbCtD
Nandrolone decanoate—MAOA—Zonisamide—epilepsy syndrome	0.235	0.44	CbGbCtD
Nandrolone decanoate—MAOA—locus ceruleus—epilepsy syndrome	0.0121	0.19	CbGeAlD
Nandrolone decanoate—MAOB—ganglion—epilepsy syndrome	0.00418	0.0658	CbGeAlD
Nandrolone decanoate—MAOA—ganglion—epilepsy syndrome	0.00356	0.0561	CbGeAlD
Nandrolone decanoate—MAOB—hindbrain—epilepsy syndrome	0.00317	0.0499	CbGeAlD
Nandrolone decanoate—MAOA—hindbrain—epilepsy syndrome	0.0027	0.0426	CbGeAlD
Nandrolone decanoate—Hyperlipidaemia—Propofol—epilepsy syndrome	0.00213	0.00816	CcSEcCtD
Nandrolone decanoate—Hirsutism—Carbamazepine—epilepsy syndrome	0.00205	0.00784	CcSEcCtD
Nandrolone decanoate—Hirsutism—Lamotrigine—epilepsy syndrome	0.00198	0.00757	CcSEcCtD
Nandrolone decanoate—Furunculosis—Pregabalin—epilepsy syndrome	0.00195	0.00744	CcSEcCtD
Nandrolone decanoate—Furuncle—Valproic Acid—epilepsy syndrome	0.00187	0.00713	CcSEcCtD
Nandrolone decanoate—CYP19A1—forebrain—epilepsy syndrome	0.00186	0.0293	CbGeAlD
Nandrolone decanoate—Dysphonia—Midazolam—epilepsy syndrome	0.00183	0.00699	CcSEcCtD
Nandrolone decanoate—MAOB—brainstem—epilepsy syndrome	0.00182	0.0286	CbGeAlD
Nandrolone decanoate—Furunculosis—Gabapentin—epilepsy syndrome	0.00178	0.00682	CcSEcCtD
Nandrolone decanoate—MAOB—forebrain—epilepsy syndrome	0.00175	0.0276	CbGeAlD
Nandrolone decanoate—Hoarseness—Gabapentin—epilepsy syndrome	0.00172	0.00659	CcSEcCtD
Nandrolone decanoate—Seborrhoeic dermatitis—Lamotrigine—epilepsy syndrome	0.00169	0.00646	CcSEcCtD
Nandrolone decanoate—Furuncle—Pregabalin—epilepsy syndrome	0.00169	0.00645	CcSEcCtD
Nandrolone decanoate—Acne—Vigabatrin—epilepsy syndrome	0.00166	0.00635	CcSEcCtD
Nandrolone decanoate—AR—forebrain—epilepsy syndrome	0.00165	0.026	CbGeAlD
Nandrolone decanoate—Irritability—Trimethadione—epilepsy syndrome	0.00162	0.00621	CcSEcCtD
Nandrolone decanoate—MAOB—telencephalon—epilepsy syndrome	0.00161	0.0254	CbGeAlD
Nandrolone decanoate—Acne—Felbamate—epilepsy syndrome	0.00158	0.00605	CcSEcCtD
Nandrolone decanoate—MAOA—brainstem—epilepsy syndrome	0.00155	0.0244	CbGeAlD
Nandrolone decanoate—Furuncle—Gabapentin—epilepsy syndrome	0.00155	0.00591	CcSEcCtD
Nandrolone decanoate—Dysphonia—Clonazepam—epilepsy syndrome	0.00153	0.00584	CcSEcCtD
Nandrolone decanoate—AR—telencephalon—epilepsy syndrome	0.00152	0.0239	CbGeAlD
Nandrolone decanoate—Dysphonia—Oxcarbazepine—epilepsy syndrome	0.00151	0.00577	CcSEcCtD
Nandrolone decanoate—MAOA—forebrain—epilepsy syndrome	0.0015	0.0235	CbGeAlD
Nandrolone decanoate—Amenorrhoea—Zonisamide—epilepsy syndrome	0.00148	0.00567	CcSEcCtD
Nandrolone decanoate—Acne—Oxcarbazepine—epilepsy syndrome	0.00148	0.00564	CcSEcCtD
Nandrolone decanoate—Libido decreased—Clobazam—epilepsy syndrome	0.00145	0.00556	CcSEcCtD
Nandrolone decanoate—Irritability—Phenobarbital—epilepsy syndrome	0.00144	0.0055	CcSEcCtD
Nandrolone decanoate—Hirsutism—Pregabalin—epilepsy syndrome	0.00142	0.00544	CcSEcCtD
Nandrolone decanoate—Hepatic function abnormal—Acetazolamide—epilepsy syndrome	0.00138	0.00526	CcSEcCtD
Nandrolone decanoate—MAOA—telencephalon—epilepsy syndrome	0.00138	0.0217	CbGeAlD
Nandrolone decanoate—Acne—Lamotrigine—epilepsy syndrome	0.00137	0.00523	CcSEcCtD
Nandrolone decanoate—Fluid retention—Fosphenytoin—epilepsy syndrome	0.00136	0.00521	CcSEcCtD
Nandrolone decanoate—Seborrhoeic dermatitis—Valproic Acid—epilepsy syndrome	0.00134	0.00513	CcSEcCtD
Nandrolone decanoate—Disturbance in sexual arousal—Clobazam—epilepsy syndrome	0.00134	0.00511	CcSEcCtD
Nandrolone decanoate—Irritability—Lacosamide—epilepsy syndrome	0.00133	0.00507	CcSEcCtD
Nandrolone decanoate—Amenorrhoea—Lamotrigine—epilepsy syndrome	0.00131	0.00501	CcSEcCtD
Nandrolone decanoate—Hirsutism—Gabapentin—epilepsy syndrome	0.0013	0.00499	CcSEcCtD
Nandrolone decanoate—Irritability—Clobazam—epilepsy syndrome	0.00129	0.00492	CcSEcCtD
Nandrolone decanoate—MAOB—medulla oblongata—epilepsy syndrome	0.00127	0.0199	CbGeAlD
Nandrolone decanoate—Gynaecomastia—Diazepam—epilepsy syndrome	0.00123	0.00471	CcSEcCtD
Nandrolone decanoate—Seborrhoeic dermatitis—Pregabalin—epilepsy syndrome	0.00121	0.00464	CcSEcCtD
Nandrolone decanoate—Fluid retention—Phenytoin—epilepsy syndrome	0.00118	0.00453	CcSEcCtD
Nandrolone decanoate—Fluid retention—Oxcarbazepine—epilepsy syndrome	0.00118	0.00451	CcSEcCtD
Nandrolone decanoate—Gynaecomastia—Zonisamide—epilepsy syndrome	0.00117	0.00446	CcSEcCtD
Nandrolone decanoate—MAOB—midbrain—epilepsy syndrome	0.00116	0.0182	CbGeAlD
Nandrolone decanoate—Hyperlipidaemia—Pregabalin—epilepsy syndrome	0.00115	0.00439	CcSEcCtD
Nandrolone decanoate—Irritability—Acetazolamide—epilepsy syndrome	0.00115	0.00439	CcSEcCtD
Nandrolone decanoate—Hepatic function abnormal—Diazepam—epilepsy syndrome	0.00114	0.00437	CcSEcCtD
Nandrolone decanoate—Fluid retention—Carbamazepine—epilepsy syndrome	0.00113	0.00432	CcSEcCtD
Nandrolone decanoate—MAOB—spinal cord—epilepsy syndrome	0.00113	0.0178	CbGeAlD
Nandrolone decanoate—Gynaecomastia—Clonazepam—epilepsy syndrome	0.00112	0.0043	CcSEcCtD
Nandrolone decanoate—Gynaecomastia—Phenytoin—epilepsy syndrome	0.00112	0.00427	CcSEcCtD
Nandrolone decanoate—Seborrhoeic dermatitis—Gabapentin—epilepsy syndrome	0.00111	0.00425	CcSEcCtD
Nandrolone decanoate—MAOA—medulla oblongata—epilepsy syndrome	0.00108	0.017	CbGeAlD
Nandrolone decanoate—CYP19A1—head—epilepsy syndrome	0.00107	0.0168	CbGeAlD
Nandrolone decanoate—Gynaecomastia—Carbamazepine—epilepsy syndrome	0.00107	0.00408	CcSEcCtD
Nandrolone decanoate—AR—spinal cord—epilepsy syndrome	0.00106	0.0167	CbGeAlD
Nandrolone decanoate—Hyperlipidaemia—Gabapentin—epilepsy syndrome	0.00105	0.00402	CcSEcCtD
Nandrolone decanoate—Irritability—Midazolam—epilepsy syndrome	0.00104	0.00399	CcSEcCtD
Nandrolone decanoate—Amenorrhoea—Valproic Acid—epilepsy syndrome	0.00104	0.00398	CcSEcCtD
Nandrolone decanoate—Hepatic function abnormal—Phenytoin—epilepsy syndrome	0.00104	0.00396	CcSEcCtD
Nandrolone decanoate—Irritability—Levetiracetam—epilepsy syndrome	0.00103	0.00394	CcSEcCtD
Nandrolone decanoate—Libido decreased—Zonisamide—epilepsy syndrome	0.00102	0.0039	CcSEcCtD
Nandrolone decanoate—CYP19A1—nervous system—epilepsy syndrome	0.00101	0.0159	CbGeAlD
Nandrolone decanoate—MAOB—head—epilepsy syndrome	0.001	0.0158	CbGeAlD
Nandrolone decanoate—Disturbance in sexual arousal—Diazepam—epilepsy syndrome	0.000991	0.00379	CcSEcCtD
Nandrolone decanoate—MAOA—midbrain—epilepsy syndrome	0.000987	0.0156	CbGeAlD
Nandrolone decanoate—Libido decreased—Clonazepam—epilepsy syndrome	0.000983	0.00376	CcSEcCtD
Nandrolone decanoate—CYP19A1—central nervous system—epilepsy syndrome	0.000973	0.0153	CbGeAlD
Nandrolone decanoate—Libido decreased—Oxcarbazepine—epilepsy syndrome	0.000972	0.00372	CcSEcCtD
Nandrolone decanoate—Irritability—Vigabatrin—epilepsy syndrome	0.000968	0.0037	CcSEcCtD
Nandrolone decanoate—MAOA—spinal cord—epilepsy syndrome	0.000963	0.0152	CbGeAlD
Nandrolone decanoate—MAOB—nervous system—epilepsy syndrome	0.000951	0.015	CbGeAlD
Nandrolone decanoate—AR—head—epilepsy syndrome	0.000944	0.0149	CbGeAlD
Nandrolone decanoate—Amenorrhoea—Pregabalin—epilepsy syndrome	0.000941	0.0036	CcSEcCtD
Nandrolone decanoate—Disturbance in sexual arousal—Zonisamide—epilepsy syndrome	0.000939	0.00359	CcSEcCtD
Nandrolone decanoate—Seborrhoeic dermatitis—Topiramate—epilepsy syndrome	0.000936	0.00358	CcSEcCtD
Nandrolone decanoate—Mediastinal disorder—Rufinamide—epilepsy syndrome	0.000922	0.00353	CcSEcCtD
Nandrolone decanoate—Dysphonia—Gabapentin—epilepsy syndrome	0.000922	0.00352	CcSEcCtD
Nandrolone decanoate—MAOB—central nervous system—epilepsy syndrome	0.000916	0.0144	CbGeAlD
Nandrolone decanoate—Disturbance in sexual arousal—Clonazepam—epilepsy syndrome	0.000905	0.00346	CcSEcCtD
Nandrolone decanoate—Irritability—Zonisamide—epilepsy syndrome	0.000903	0.00345	CcSEcCtD
Nandrolone decanoate—Acne—Gabapentin—epilepsy syndrome	0.000901	0.00345	CcSEcCtD
Nandrolone decanoate—Libido decreased—Lamotrigine—epilepsy syndrome	0.000901	0.00345	CcSEcCtD
Nandrolone decanoate—MAOB—cerebellum—epilepsy syndrome	0.000895	0.0141	CbGeAlD
Nandrolone decanoate—AR—nervous system—epilepsy syndrome	0.000895	0.0141	CbGeAlD
Nandrolone decanoate—Disturbance in sexual arousal—Oxcarbazepine—epilepsy syndrome	0.000894	0.00342	CcSEcCtD
Nandrolone decanoate—Norgestimate—ABCC2—epilepsy syndrome	0.000892	0.244	CrCbGaD
Nandrolone decanoate—Hyperlipidaemia—Topiramate—epilepsy syndrome	0.000885	0.00338	CcSEcCtD
Nandrolone decanoate—Irritability—Clonazepam—epilepsy syndrome	0.00087	0.00333	CcSEcCtD
Nandrolone decanoate—Irritability—Phenytoin—epilepsy syndrome	0.000865	0.00331	CcSEcCtD
Nandrolone decanoate—Amenorrhoea—Gabapentin—epilepsy syndrome	0.000863	0.0033	CcSEcCtD
Nandrolone decanoate—AR—central nervous system—epilepsy syndrome	0.000862	0.0136	CbGeAlD
Nandrolone decanoate—Irritability—Oxcarbazepine—epilepsy syndrome	0.00086	0.00329	CcSEcCtD
Nandrolone decanoate—MAOA—head—epilepsy syndrome	0.000856	0.0135	CbGeAlD
Nandrolone decanoate—Disturbance in sexual arousal—Lamotrigine—epilepsy syndrome	0.000829	0.00317	CcSEcCtD
Nandrolone decanoate—Irritability—Carbamazepine—epilepsy syndrome	0.000825	0.00316	CcSEcCtD
Nandrolone decanoate—MAOA—nervous system—epilepsy syndrome	0.000812	0.0128	CbGeAlD
Nandrolone decanoate—Erectile dysfunction—Vigabatrin—epilepsy syndrome	0.000808	0.00309	CcSEcCtD
Nandrolone decanoate—Irritability—Lamotrigine—epilepsy syndrome	0.000798	0.00305	CcSEcCtD
Nandrolone decanoate—Erectile dysfunction—Diazepam—epilepsy syndrome	0.000795	0.00304	CcSEcCtD
Nandrolone decanoate—Fluid retention—Pregabalin—epilepsy syndrome	0.000785	0.003	CcSEcCtD
Nandrolone decanoate—MAOA—central nervous system—epilepsy syndrome	0.000782	0.0123	CbGeAlD
Nandrolone decanoate—Dysphonia—Topiramate—epilepsy syndrome	0.000776	0.00297	CcSEcCtD
Nandrolone decanoate—CYP19A1—brain—epilepsy syndrome	0.000773	0.0122	CbGeAlD
Nandrolone decanoate—MAOA—cerebellum—epilepsy syndrome	0.000764	0.012	CbGeAlD
Nandrolone decanoate—Hepatic function abnormal—Valproic Acid—epilepsy syndrome	0.00076	0.00291	CcSEcCtD
Nandrolone decanoate—Acne—Topiramate—epilepsy syndrome	0.000758	0.0029	CcSEcCtD
Nandrolone decanoate—Erectile dysfunction—Zonisamide—epilepsy syndrome	0.000753	0.00288	CcSEcCtD
Nandrolone decanoate—Jaundice—Diazepam—epilepsy syndrome	0.00075	0.00287	CcSEcCtD
Nandrolone decanoate—Gynaecomastia—Pregabalin—epilepsy syndrome	0.00074	0.00283	CcSEcCtD
Nandrolone decanoate—MAOB—brain—epilepsy syndrome	0.000727	0.0115	CbGeAlD
Nandrolone decanoate—Jaundice—Felbamate—epilepsy syndrome	0.000726	0.00278	CcSEcCtD
Nandrolone decanoate—Amenorrhoea—Topiramate—epilepsy syndrome	0.000726	0.00278	CcSEcCtD
Nandrolone decanoate—Erectile dysfunction—Clonazepam—epilepsy syndrome	0.000726	0.00278	CcSEcCtD
Nandrolone decanoate—Fluid retention—Gabapentin—epilepsy syndrome	0.00072	0.00275	CcSEcCtD
Nandrolone decanoate—Erectile dysfunction—Carbamazepine—epilepsy syndrome	0.000688	0.00263	CcSEcCtD
Nandrolone decanoate—AR—brain—epilepsy syndrome	0.000684	0.0108	CbGeAlD
Nandrolone decanoate—Mediastinal disorder—Midazolam—epilepsy syndrome	0.000681	0.0026	CcSEcCtD
Nandrolone decanoate—Gynaecomastia—Gabapentin—epilepsy syndrome	0.000679	0.00259	CcSEcCtD
Nandrolone decanoate—Mediastinal disorder—Levetiracetam—epilepsy syndrome	0.000672	0.00257	CcSEcCtD
Nandrolone decanoate—Erectile dysfunction—Lamotrigine—epilepsy syndrome	0.000665	0.00254	CcSEcCtD
Nandrolone decanoate—Jaundice—Carbamazepine—epilepsy syndrome	0.00065	0.00248	CcSEcCtD
Nandrolone decanoate—Libido decreased—Pregabalin—epilepsy syndrome	0.000647	0.00248	CcSEcCtD
Nandrolone decanoate—Hepatic function abnormal—Gabapentin—epilepsy syndrome	0.00063	0.00241	CcSEcCtD
Nandrolone decanoate—Rash—Amobarbital—epilepsy syndrome	0.000622	0.00238	CcSEcCtD
Nandrolone decanoate—Dermatitis—Amobarbital—epilepsy syndrome	0.000622	0.00238	CcSEcCtD
Nandrolone decanoate—MAOA—brain—epilepsy syndrome	0.00062	0.00977	CbGeAlD
Nandrolone decanoate—Fluid retention—Topiramate—epilepsy syndrome	0.000606	0.00232	CcSEcCtD
Nandrolone decanoate—Rash—Primidone—epilepsy syndrome	0.0006	0.00229	CcSEcCtD
Nandrolone decanoate—Dermatitis—Primidone—epilepsy syndrome	0.000599	0.00229	CcSEcCtD
Nandrolone decanoate—Disturbance in sexual arousal—Pregabalin—epilepsy syndrome	0.000596	0.00228	CcSEcCtD
Nandrolone decanoate—Libido decreased—Gabapentin—epilepsy syndrome	0.000594	0.00227	CcSEcCtD
Nandrolone decanoate—Pruritus—Trimethadione—epilepsy syndrome	0.000592	0.00226	CcSEcCtD
Nandrolone decanoate—Mediastinal disorder—Zonisamide—epilepsy syndrome	0.00059	0.00226	CcSEcCtD
Nandrolone decanoate—Urticaria—Phenobarbital—epilepsy syndrome	0.000589	0.00225	CcSEcCtD
Nandrolone decanoate—Nausea—Amobarbital—epilepsy syndrome	0.000586	0.00224	CcSEcCtD
Nandrolone decanoate—Hypertension—Propofol—epilepsy syndrome	0.00058	0.00222	CcSEcCtD
Nandrolone decanoate—Irritability—Pregabalin—epilepsy syndrome	0.000573	0.00219	CcSEcCtD
Nandrolone decanoate—Nausea—Primidone—epilepsy syndrome	0.000565	0.00216	CcSEcCtD
Nandrolone decanoate—Oedema—Propofol—epilepsy syndrome	0.000549	0.0021	CcSEcCtD
Nandrolone decanoate—Disturbance in sexual arousal—Gabapentin—epilepsy syndrome	0.000546	0.00209	CcSEcCtD
Nandrolone decanoate—Urticaria—Lacosamide—epilepsy syndrome	0.000542	0.00207	CcSEcCtD
Nandrolone decanoate—Hypertension—Fosphenytoin—epilepsy syndrome	0.000541	0.00207	CcSEcCtD
Nandrolone decanoate—Mediastinal disorder—Carbamazepine—epilepsy syndrome	0.000539	0.00206	CcSEcCtD
Nandrolone decanoate—Rash—Trimethadione—epilepsy syndrome	0.000527	0.00202	CcSEcCtD
Nandrolone decanoate—Dermatitis—Trimethadione—epilepsy syndrome	0.000527	0.00201	CcSEcCtD
Nandrolone decanoate—Urticaria—Clobazam—epilepsy syndrome	0.000526	0.00201	CcSEcCtD
Nandrolone decanoate—Irritability—Gabapentin—epilepsy syndrome	0.000525	0.00201	CcSEcCtD
Nandrolone decanoate—Mediastinal disorder—Lamotrigine—epilepsy syndrome	0.000521	0.00199	CcSEcCtD
Nandrolone decanoate—Pruritus—Rufinamide—epilepsy syndrome	0.000514	0.00197	CcSEcCtD
Nandrolone decanoate—Testosterone—SLCO1A2—epilepsy syndrome	0.00051	0.139	CrCbGaD
Nandrolone decanoate—Hypertension—Felbamate—epilepsy syndrome	0.000503	0.00192	CcSEcCtD
Nandrolone decanoate—Libido decreased—Topiramate—epilepsy syndrome	0.000499	0.00191	CcSEcCtD
Nandrolone decanoate—Oedema—Vigabatrin—epilepsy syndrome	0.000499	0.00191	CcSEcCtD
Nandrolone decanoate—Nausea—Trimethadione—epilepsy syndrome	0.000497	0.0019	CcSEcCtD
Nandrolone decanoate—Hypertension—Zonisamide—epilepsy syndrome	0.000492	0.00188	CcSEcCtD
Nandrolone decanoate—Pruritus—Lacosamide—epilepsy syndrome	0.000483	0.00185	CcSEcCtD
Nandrolone decanoate—Erectile dysfunction—Pregabalin—epilepsy syndrome	0.000478	0.00183	CcSEcCtD
Nandrolone decanoate—Oedema—Felbamate—epilepsy syndrome	0.000475	0.00182	CcSEcCtD
Nandrolone decanoate—Hypertension—Phenytoin—epilepsy syndrome	0.000471	0.0018	CcSEcCtD
Nandrolone decanoate—Urticaria—Acetazolamide—epilepsy syndrome	0.000469	0.00179	CcSEcCtD
Nandrolone decanoate—Pruritus—Clobazam—epilepsy syndrome	0.000469	0.00179	CcSEcCtD
Nandrolone decanoate—Hypertension—Oxcarbazepine—epilepsy syndrome	0.000468	0.00179	CcSEcCtD
Nandrolone decanoate—Rash—Phenobarbital—epilepsy syndrome	0.000467	0.00179	CcSEcCtD
Nandrolone decanoate—Dermatitis—Phenobarbital—epilepsy syndrome	0.000467	0.00178	CcSEcCtD
Nandrolone decanoate—Oedema—Zonisamide—epilepsy syndrome	0.000465	0.00178	CcSEcCtD
Nandrolone decanoate—Disturbance in sexual arousal—Topiramate—epilepsy syndrome	0.000459	0.00176	CcSEcCtD
Nandrolone decanoate—Rash—Rufinamide—epilepsy syndrome	0.000458	0.00175	CcSEcCtD
Nandrolone decanoate—Dermatitis—Rufinamide—epilepsy syndrome	0.000458	0.00175	CcSEcCtD
Nandrolone decanoate—Jaundice—Pregabalin—epilepsy syndrome	0.000451	0.00172	CcSEcCtD
Nandrolone decanoate—Hypertension—Carbamazepine—epilepsy syndrome	0.00045	0.00172	CcSEcCtD
Nandrolone decanoate—Oedema—Clonazepam—epilepsy syndrome	0.000448	0.00171	CcSEcCtD
Nandrolone decanoate—Testosterone—CYP11A1—epilepsy syndrome	0.000444	0.121	CrCbGaD
Nandrolone decanoate—Irritability—Topiramate—epilepsy syndrome	0.000442	0.00169	CcSEcCtD
Nandrolone decanoate—Nausea—Phenobarbital—epilepsy syndrome	0.00044	0.00168	CcSEcCtD
Nandrolone decanoate—Erectile dysfunction—Gabapentin—epilepsy syndrome	0.000438	0.00168	CcSEcCtD
Nandrolone decanoate—Urticaria—Propofol—epilepsy syndrome	0.000436	0.00167	CcSEcCtD
Nandrolone decanoate—Hypertension—Lamotrigine—epilepsy syndrome	0.000434	0.00166	CcSEcCtD
Nandrolone decanoate—Nausea—Rufinamide—epilepsy syndrome	0.000432	0.00165	CcSEcCtD
Nandrolone decanoate—Rash—Lacosamide—epilepsy syndrome	0.000431	0.00165	CcSEcCtD
Nandrolone decanoate—Dermatitis—Lacosamide—epilepsy syndrome	0.00043	0.00164	CcSEcCtD
Nandrolone decanoate—Urticaria—Midazolam—epilepsy syndrome	0.000426	0.00163	CcSEcCtD
Nandrolone decanoate—Oedema—Carbamazepine—epilepsy syndrome	0.000425	0.00163	CcSEcCtD
Nandrolone decanoate—Rash—Clobazam—epilepsy syndrome	0.000418	0.0016	CcSEcCtD
Nandrolone decanoate—Dermatitis—Clobazam—epilepsy syndrome	0.000417	0.0016	CcSEcCtD
Nandrolone decanoate—Mediastinal disorder—Valproic Acid—epilepsy syndrome	0.000414	0.00158	CcSEcCtD
Nandrolone decanoate—Jaundice—Gabapentin—epilepsy syndrome	0.000414	0.00158	CcSEcCtD
Nandrolone decanoate—Oedema—Lamotrigine—epilepsy syndrome	0.000411	0.00157	CcSEcCtD
Nandrolone decanoate—Urticaria—Fosphenytoin—epilepsy syndrome	0.000406	0.00155	CcSEcCtD
Nandrolone decanoate—Nausea—Lacosamide—epilepsy syndrome	0.000406	0.00155	CcSEcCtD
Nandrolone decanoate—Urticaria—Vigabatrin—epilepsy syndrome	0.000396	0.00151	CcSEcCtD
Nandrolone decanoate—Nausea—Clobazam—epilepsy syndrome	0.000394	0.00151	CcSEcCtD
Nandrolone decanoate—Urticaria—Diazepam—epilepsy syndrome	0.00039	0.00149	CcSEcCtD
Nandrolone decanoate—Pruritus—Propofol—epilepsy syndrome	0.000388	0.00148	CcSEcCtD
Nandrolone decanoate—Pruritus—Midazolam—epilepsy syndrome	0.00038	0.00145	CcSEcCtD
Nandrolone decanoate—Urticaria—Felbamate—epilepsy syndrome	0.000377	0.00144	CcSEcCtD
Nandrolone decanoate—Pruritus—Levetiracetam—epilepsy syndrome	0.000375	0.00143	CcSEcCtD
Nandrolone decanoate—Mediastinal disorder—Pregabalin—epilepsy syndrome	0.000374	0.00143	CcSEcCtD
Nandrolone decanoate—Urticaria—Zonisamide—epilepsy syndrome	0.000369	0.00141	CcSEcCtD
Nandrolone decanoate—Erectile dysfunction—Topiramate—epilepsy syndrome	0.000369	0.00141	CcSEcCtD
Nandrolone decanoate—Pruritus—Fosphenytoin—epilepsy syndrome	0.000362	0.00138	CcSEcCtD
Nandrolone decanoate—Urticaria—Clonazepam—epilepsy syndrome	0.000356	0.00136	CcSEcCtD
Nandrolone decanoate—Urticaria—Phenytoin—epilepsy syndrome	0.000354	0.00135	CcSEcCtD
Nandrolone decanoate—Pruritus—Vigabatrin—epilepsy syndrome	0.000353	0.00135	CcSEcCtD
Nandrolone decanoate—Urticaria—Oxcarbazepine—epilepsy syndrome	0.000352	0.00135	CcSEcCtD
Nandrolone decanoate—Nausea—Acetazolamide—epilepsy syndrome	0.000351	0.00134	CcSEcCtD
Nandrolone decanoate—Pruritus—Diazepam—epilepsy syndrome	0.000347	0.00133	CcSEcCtD
Nandrolone decanoate—Rash—Propofol—epilepsy syndrome	0.000346	0.00132	CcSEcCtD
Nandrolone decanoate—Dermatitis—Propofol—epilepsy syndrome	0.000346	0.00132	CcSEcCtD
Nandrolone decanoate—Hypertension—Valproic Acid—epilepsy syndrome	0.000345	0.00132	CcSEcCtD
Nandrolone decanoate—Mediastinal disorder—Gabapentin—epilepsy syndrome	0.000343	0.00131	CcSEcCtD
Nandrolone decanoate—Rash—Midazolam—epilepsy syndrome	0.000338	0.00129	CcSEcCtD
Nandrolone decanoate—Dermatitis—Midazolam—epilepsy syndrome	0.000338	0.00129	CcSEcCtD
Nandrolone decanoate—Urticaria—Carbamazepine—epilepsy syndrome	0.000338	0.00129	CcSEcCtD
Nandrolone decanoate—Pruritus—Felbamate—epilepsy syndrome	0.000336	0.00129	CcSEcCtD
Nandrolone decanoate—Rash—Levetiracetam—epilepsy syndrome	0.000334	0.00128	CcSEcCtD
Nandrolone decanoate—Dermatitis—Levetiracetam—epilepsy syndrome	0.000334	0.00128	CcSEcCtD
Nandrolone decanoate—Pruritus—Zonisamide—epilepsy syndrome	0.000329	0.00126	CcSEcCtD
Nandrolone decanoate—Oedema—Valproic Acid—epilepsy syndrome	0.000326	0.00125	CcSEcCtD
Nandrolone decanoate—Urticaria—Lamotrigine—epilepsy syndrome	0.000326	0.00125	CcSEcCtD
Nandrolone decanoate—Nausea—Propofol—epilepsy syndrome	0.000326	0.00125	CcSEcCtD
Nandrolone decanoate—Rash—Fosphenytoin—epilepsy syndrome	0.000323	0.00123	CcSEcCtD
Nandrolone decanoate—Dermatitis—Fosphenytoin—epilepsy syndrome	0.000322	0.00123	CcSEcCtD
Nandrolone decanoate—Nausea—Midazolam—epilepsy syndrome	0.000319	0.00122	CcSEcCtD
Nandrolone decanoate—Pruritus—Clonazepam—epilepsy syndrome	0.000317	0.00121	CcSEcCtD
Nandrolone decanoate—Pruritus—Phenytoin—epilepsy syndrome	0.000315	0.0012	CcSEcCtD
Nandrolone decanoate—Nausea—Levetiracetam—epilepsy syndrome	0.000315	0.0012	CcSEcCtD
Nandrolone decanoate—Rash—Vigabatrin—epilepsy syndrome	0.000314	0.0012	CcSEcCtD
Nandrolone decanoate—Dermatitis—Vigabatrin—epilepsy syndrome	0.000314	0.0012	CcSEcCtD
Nandrolone decanoate—Pruritus—Oxcarbazepine—epilepsy syndrome	0.000313	0.0012	CcSEcCtD
Nandrolone decanoate—Hypertension—Pregabalin—epilepsy syndrome	0.000312	0.00119	CcSEcCtD
Nandrolone decanoate—Rash—Diazepam—epilepsy syndrome	0.00031	0.00118	CcSEcCtD
Nandrolone decanoate—Dermatitis—Diazepam—epilepsy syndrome	0.000309	0.00118	CcSEcCtD
Nandrolone decanoate—Norethindrone—CYP2C19—epilepsy syndrome	0.000308	0.0841	CrCbGaD
Nandrolone decanoate—Nausea—Fosphenytoin—epilepsy syndrome	0.000304	0.00116	CcSEcCtD
Nandrolone decanoate—Pruritus—Carbamazepine—epilepsy syndrome	0.000301	0.00115	CcSEcCtD
Nandrolone decanoate—Rash—Felbamate—epilepsy syndrome	0.0003	0.00115	CcSEcCtD
Nandrolone decanoate—Dermatitis—Felbamate—epilepsy syndrome	0.000299	0.00114	CcSEcCtD
Nandrolone decanoate—Nausea—Vigabatrin—epilepsy syndrome	0.000296	0.00113	CcSEcCtD
Nandrolone decanoate—Oedema—Pregabalin—epilepsy syndrome	0.000295	0.00113	CcSEcCtD
Nandrolone decanoate—Rash—Zonisamide—epilepsy syndrome	0.000293	0.00112	CcSEcCtD
Nandrolone decanoate—Dermatitis—Zonisamide—epilepsy syndrome	0.000293	0.00112	CcSEcCtD
Nandrolone decanoate—Nausea—Diazepam—epilepsy syndrome	0.000292	0.00111	CcSEcCtD
Nandrolone decanoate—Pruritus—Lamotrigine—epilepsy syndrome	0.000291	0.00111	CcSEcCtD
Nandrolone decanoate—Mediastinal disorder—Topiramate—epilepsy syndrome	0.000289	0.0011	CcSEcCtD
Nandrolone decanoate—Hypertension—Gabapentin—epilepsy syndrome	0.000286	0.00109	CcSEcCtD
Nandrolone decanoate—Rash—Clonazepam—epilepsy syndrome	0.000283	0.00108	CcSEcCtD
Nandrolone decanoate—Dermatitis—Clonazepam—epilepsy syndrome	0.000282	0.00108	CcSEcCtD
Nandrolone decanoate—Nausea—Felbamate—epilepsy syndrome	0.000282	0.00108	CcSEcCtD
Nandrolone decanoate—Rash—Phenytoin—epilepsy syndrome	0.000281	0.00107	CcSEcCtD
Nandrolone decanoate—Dermatitis—Phenytoin—epilepsy syndrome	0.00028	0.00107	CcSEcCtD
Nandrolone decanoate—Rash—Oxcarbazepine—epilepsy syndrome	0.000279	0.00107	CcSEcCtD
Nandrolone decanoate—Dermatitis—Oxcarbazepine—epilepsy syndrome	0.000279	0.00107	CcSEcCtD
Nandrolone decanoate—Nausea—Zonisamide—epilepsy syndrome	0.000276	0.00106	CcSEcCtD
Nandrolone decanoate—Oedema—Gabapentin—epilepsy syndrome	0.000271	0.00103	CcSEcCtD
Nandrolone decanoate—Rash—Carbamazepine—epilepsy syndrome	0.000268	0.00102	CcSEcCtD
Nandrolone decanoate—Dermatitis—Carbamazepine—epilepsy syndrome	0.000268	0.00102	CcSEcCtD
Nandrolone decanoate—Nausea—Clonazepam—epilepsy syndrome	0.000266	0.00102	CcSEcCtD
Nandrolone decanoate—Nausea—Phenytoin—epilepsy syndrome	0.000264	0.00101	CcSEcCtD
Nandrolone decanoate—Nausea—Oxcarbazepine—epilepsy syndrome	0.000263	0.00101	CcSEcCtD
Nandrolone decanoate—Urticaria—Valproic Acid—epilepsy syndrome	0.000259	0.000991	CcSEcCtD
Nandrolone decanoate—Rash—Lamotrigine—epilepsy syndrome	0.000259	0.00099	CcSEcCtD
Nandrolone decanoate—Dermatitis—Lamotrigine—epilepsy syndrome	0.000259	0.000989	CcSEcCtD
Nandrolone decanoate—Nausea—Carbamazepine—epilepsy syndrome	0.000252	0.000965	CcSEcCtD
Nandrolone decanoate—Nausea—Lamotrigine—epilepsy syndrome	0.000244	0.000933	CcSEcCtD
Nandrolone decanoate—Hypertension—Topiramate—epilepsy syndrome	0.000241	0.000921	CcSEcCtD
Nandrolone decanoate—Urticaria—Pregabalin—epilepsy syndrome	0.000234	0.000896	CcSEcCtD
Nandrolone decanoate—Pruritus—Valproic Acid—epilepsy syndrome	0.000231	0.000883	CcSEcCtD
Nandrolone decanoate—Oedema—Topiramate—epilepsy syndrome	0.000228	0.00087	CcSEcCtD
Nandrolone decanoate—Testosterone—ABCG2—epilepsy syndrome	0.000215	0.0589	CrCbGaD
Nandrolone decanoate—Urticaria—Gabapentin—epilepsy syndrome	0.000215	0.000822	CcSEcCtD
Nandrolone decanoate—Pruritus—Pregabalin—epilepsy syndrome	0.000209	0.000798	CcSEcCtD
Nandrolone decanoate—Rash—Valproic Acid—epilepsy syndrome	0.000206	0.000787	CcSEcCtD
Nandrolone decanoate—Dermatitis—Valproic Acid—epilepsy syndrome	0.000206	0.000786	CcSEcCtD
Nandrolone decanoate—Progesterone—NR3C1—epilepsy syndrome	0.000197	0.0537	CrCbGaD
Nandrolone decanoate—Nausea—Valproic Acid—epilepsy syndrome	0.000194	0.000741	CcSEcCtD
Nandrolone decanoate—Pruritus—Gabapentin—epilepsy syndrome	0.000191	0.000732	CcSEcCtD
Nandrolone decanoate—Rash—Pregabalin—epilepsy syndrome	0.000186	0.000711	CcSEcCtD
Nandrolone decanoate—Dermatitis—Pregabalin—epilepsy syndrome	0.000186	0.000711	CcSEcCtD
Nandrolone decanoate—Urticaria—Topiramate—epilepsy syndrome	0.000181	0.000691	CcSEcCtD
Nandrolone decanoate—Progesterone—CYP2C19—epilepsy syndrome	0.000179	0.049	CrCbGaD
Nandrolone decanoate—Nausea—Pregabalin—epilepsy syndrome	0.000175	0.00067	CcSEcCtD
Nandrolone decanoate—Rash—Gabapentin—epilepsy syndrome	0.000171	0.000652	CcSEcCtD
Nandrolone decanoate—Norethindrone—ALB—epilepsy syndrome	0.000171	0.0466	CrCbGaD
Nandrolone decanoate—Dermatitis—Gabapentin—epilepsy syndrome	0.00017	0.000652	CcSEcCtD
Nandrolone decanoate—Testosterone—CYP2C19—epilepsy syndrome	0.000169	0.0463	CrCbGaD
Nandrolone decanoate—Norethindrone—ABCB1—epilepsy syndrome	0.000163	0.0445	CrCbGaD
Nandrolone decanoate—Pruritus—Topiramate—epilepsy syndrome	0.000161	0.000616	CcSEcCtD
Nandrolone decanoate—Nausea—Gabapentin—epilepsy syndrome	0.000161	0.000615	CcSEcCtD
Nandrolone decanoate—Rash—Topiramate—epilepsy syndrome	0.000144	0.000549	CcSEcCtD
Nandrolone decanoate—Dermatitis—Topiramate—epilepsy syndrome	0.000143	0.000548	CcSEcCtD
Nandrolone decanoate—Nausea—Topiramate—epilepsy syndrome	0.000135	0.000517	CcSEcCtD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—SIRT1—epilepsy syndrome	0.000134	0.000978	CbGpPWpGaD
Nandrolone decanoate—AR—SIDS Susceptibility Pathways—HTR2A—epilepsy syndrome	0.000133	0.000976	CbGpPWpGaD
Nandrolone decanoate—Progesterone—CYP2D6—epilepsy syndrome	0.000133	0.0363	CrCbGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—ABCB1—epilepsy syndrome	0.000132	0.000966	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—CA13—epilepsy syndrome	0.000132	0.000965	CbGpPWpGaD
Nandrolone decanoate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—JUN—epilepsy syndrome	0.000131	0.000956	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—COX3—epilepsy syndrome	0.000131	0.000955	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—TSC2—epilepsy syndrome	0.00013	0.000951	CbGpPWpGaD
Nandrolone decanoate—MAOA—Neuronal System—CHRNA4—epilepsy syndrome	0.00013	0.000948	CbGpPWpGaD
Nandrolone decanoate—AR—Regulation of nuclear SMAD2/3 signaling—JUN—epilepsy syndrome	0.00013	0.000946	CbGpPWpGaD
Nandrolone decanoate—MAOA—SIDS Susceptibility Pathways—MEF2C—epilepsy syndrome	0.000129	0.000946	CbGpPWpGaD
Nandrolone decanoate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—epilepsy syndrome	0.000127	0.00093	CbGpPWpGaD
Nandrolone decanoate—MAOA—SIDS Susceptibility Pathways—YWHAZ—epilepsy syndrome	0.000125	0.000914	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—KCNB1—epilepsy syndrome	0.000124	0.000906	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—SLCO1A2—epilepsy syndrome	0.000124	0.000906	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—PFKL—epilepsy syndrome	0.000124	0.000906	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—CACNA2D2—epilepsy syndrome	0.000124	0.000906	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—SLC6A8—epilepsy syndrome	0.000124	0.000906	CbGpPWpGaD
Nandrolone decanoate—MAOA—SIDS Susceptibility Pathways—NGF—epilepsy syndrome	0.000124	0.000904	CbGpPWpGaD
Nandrolone decanoate—MAOA—SIDS Susceptibility Pathways—NR3C1—epilepsy syndrome	0.000123	0.0009	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—ATM—epilepsy syndrome	0.000123	0.000896	CbGpPWpGaD
Nandrolone decanoate—AR—Androgen receptor signaling pathway—JUN—epilepsy syndrome	0.00012	0.000878	CbGpPWpGaD
Nandrolone decanoate—MAOA—SIDS Susceptibility Pathways—HTR2A—epilepsy syndrome	0.000118	0.000861	CbGpPWpGaD
Nandrolone decanoate—MAOA—Neuronal System—BCHE—epilepsy syndrome	0.000114	0.000835	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—QARS—epilepsy syndrome	0.000113	0.000829	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—NEU1—epilepsy syndrome	0.000113	0.000828	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—UPB1—epilepsy syndrome	0.000113	0.000828	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—ATIC—epilepsy syndrome	0.000113	0.000828	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—TSC2—epilepsy syndrome	0.000112	0.000818	CbGpPWpGaD
Nandrolone decanoate—MAOA—Neuronal System—DLG4—epilepsy syndrome	0.000112	0.000815	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—HSD17B4—epilepsy syndrome	0.000109	0.000797	CbGpPWpGaD
Nandrolone decanoate—MAOA—Neuronal System—GRIN2B—epilepsy syndrome	0.000109	0.000797	CbGpPWpGaD
Nandrolone decanoate—MAOA—Neuronal System—PLCB1—epilepsy syndrome	0.000108	0.000788	CbGpPWpGaD
Nandrolone decanoate—AR—Androgen receptor signaling pathway—SRC—epilepsy syndrome	0.000108	0.000787	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—CASP8—epilepsy syndrome	0.000107	0.000782	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism of lipids and lipoproteins—TXNRD1—epilepsy syndrome	0.000106	0.000777	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—ATM—epilepsy syndrome	0.000106	0.000771	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—GBE1—epilepsy syndrome	0.000105	0.00077	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—PPP1R3C—epilepsy syndrome	0.000105	0.00077	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—FAR1—epilepsy syndrome	0.000103	0.00075	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—ADK—epilepsy syndrome	0.000103	0.00075	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—GLUD1—epilepsy syndrome	0.000103	0.00075	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—PDXK—epilepsy syndrome	0.000103	0.00075	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—CERS1—epilepsy syndrome	0.000103	0.00075	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—L2HGDH—epilepsy syndrome	0.000103	0.00075	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—ATM—epilepsy syndrome	0.000102	0.000743	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—L2HGDH—epilepsy syndrome	0.0001	0.000731	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—PDXK—epilepsy syndrome	0.0001	0.000731	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—GLUD1—epilepsy syndrome	0.0001	0.000731	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—CERS1—epilepsy syndrome	0.0001	0.000731	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—FAR1—epilepsy syndrome	0.0001	0.000731	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—ADK—epilepsy syndrome	0.0001	0.000731	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—ASAH1—epilepsy syndrome	9.91e-05	0.000724	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—STXBP1—epilepsy syndrome	9.64e-05	0.000704	CbGpPWpGaD
Nandrolone decanoate—Progesterone—ABCB1—epilepsy syndrome	9.49e-05	0.0259	CrCbGaD
Nandrolone decanoate—Testosterone—ALB—epilepsy syndrome	9.4e-05	0.0257	CrCbGaD
Nandrolone decanoate—MAOB—Metabolism—NT5E—epilepsy syndrome	9.39e-05	0.000686	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—ALAD—epilepsy syndrome	9.39e-05	0.000686	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—PNPO—epilepsy syndrome	9.39e-05	0.000686	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—GAMT—epilepsy syndrome	9.39e-05	0.000686	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—EPM2A—epilepsy syndrome	9.39e-05	0.000686	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—NHLRC1—epilepsy syndrome	9.39e-05	0.000686	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—CASP8—epilepsy syndrome	9.21e-05	0.000673	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—BCL2—epilepsy syndrome	9.19e-05	0.000671	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—PNPO—epilepsy syndrome	9.15e-05	0.000669	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—GAMT—epilepsy syndrome	9.15e-05	0.000669	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—NHLRC1—epilepsy syndrome	9.15e-05	0.000669	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—EPM2A—epilepsy syndrome	9.15e-05	0.000669	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—EIF2B5—epilepsy syndrome	9.06e-05	0.000662	CbGpPWpGaD
Nandrolone decanoate—AR—Coregulation of Androgen receptor activity—AKT1—epilepsy syndrome	9.06e-05	0.000662	CbGpPWpGaD
Nandrolone decanoate—Testosterone—ABCB1—epilepsy syndrome	8.97e-05	0.0245	CrCbGaD
Nandrolone decanoate—MAOB—Metabolism—CACNA1A—epilepsy syndrome	8.96e-05	0.000655	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—ALDH7A1—epilepsy syndrome	8.96e-05	0.000655	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—CASP8—epilepsy syndrome	8.87e-05	0.000648	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—MTOR—epilepsy syndrome	8.81e-05	0.000644	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—ST3GAL3—epilepsy syndrome	8.77e-05	0.000641	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—CA4—epilepsy syndrome	8.73e-05	0.000638	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—QDPR—epilepsy syndrome	8.73e-05	0.000638	CbGpPWpGaD
Nandrolone decanoate—MAOA—Biological oxidations—POMC—epilepsy syndrome	8.7e-05	0.000636	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—ADSL—epilepsy syndrome	8.59e-05	0.000628	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—CA4—epilepsy syndrome	8.51e-05	0.000622	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—QDPR—epilepsy syndrome	8.51e-05	0.000622	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Biological oxidations—POMC—epilepsy syndrome	8.48e-05	0.00062	CbGpPWpGaD
Nandrolone decanoate—MAOA—Transmission across Chemical Synapses—PRKCB—epilepsy syndrome	8.46e-05	0.000618	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—GLUL—epilepsy syndrome	8.42e-05	0.000616	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—CACNA1D—epilepsy syndrome	8.27e-05	0.000604	CbGpPWpGaD
Nandrolone decanoate—AR—Generic Transcription Pathway—JUNB—epilepsy syndrome	8.25e-05	0.000603	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—COX3—epilepsy syndrome	8.2e-05	0.0006	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—TFAM—epilepsy syndrome	8.2e-05	0.000599	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—CASP3—epilepsy syndrome	8.1e-05	0.000592	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—FGF2—epilepsy syndrome	8.02e-05	0.000586	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—COX3—epilepsy syndrome	8e-05	0.000585	CbGpPWpGaD
Nandrolone decanoate—AR—SIDS Susceptibility Pathways—IL1B—epilepsy syndrome	7.91e-05	0.000578	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—BCL2—epilepsy syndrome	7.91e-05	0.000578	CbGpPWpGaD
Nandrolone decanoate—AR—SIDS Susceptibility Pathways—CASP3—epilepsy syndrome	7.89e-05	0.000577	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—JUN—epilepsy syndrome	7.87e-05	0.000575	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—SLCO1A2—epilepsy syndrome	7.78e-05	0.000568	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—PFKL—epilepsy syndrome	7.78e-05	0.000568	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—CACNA2D2—epilepsy syndrome	7.78e-05	0.000568	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—KCNB1—epilepsy syndrome	7.78e-05	0.000568	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—SLC6A8—epilepsy syndrome	7.78e-05	0.000568	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—TXNRD1—epilepsy syndrome	7.73e-05	0.000565	CbGpPWpGaD
Nandrolone decanoate—AR—SIDS Susceptibility Pathways—JUN—epilepsy syndrome	7.67e-05	0.00056	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—BCL2—epilepsy syndrome	7.61e-05	0.000556	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—SLC6A8—epilepsy syndrome	7.59e-05	0.000554	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—KCNB1—epilepsy syndrome	7.59e-05	0.000554	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—SLCO1A2—epilepsy syndrome	7.59e-05	0.000554	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—PFKL—epilepsy syndrome	7.59e-05	0.000554	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—CACNA2D2—epilepsy syndrome	7.59e-05	0.000554	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—MTOR—epilepsy syndrome	7.58e-05	0.000554	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—AQP1—epilepsy syndrome	7.51e-05	0.000549	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism of lipids and lipoproteins—CYP2C19—epilepsy syndrome	7.41e-05	0.000542	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism of lipids and lipoproteins—CYP11A1—epilepsy syndrome	7.37e-05	0.000538	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—PTGS2—epilepsy syndrome	7.23e-05	0.000529	CbGpPWpGaD
Nandrolone decanoate—AR—Regulation of nuclear SMAD2/3 signaling—AKT1—epilepsy syndrome	7.22e-05	0.000528	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—NEU1—epilepsy syndrome	7.11e-05	0.00052	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—UPB1—epilepsy syndrome	7.11e-05	0.00052	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—ATIC—epilepsy syndrome	7.11e-05	0.00052	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—SNRPE—epilepsy syndrome	7.08e-05	0.000517	CbGpPWpGaD
Nandrolone decanoate—MAOA—SIDS Susceptibility Pathways—IL1B—epilepsy syndrome	6.98e-05	0.00051	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—CASP3—epilepsy syndrome	6.97e-05	0.000509	CbGpPWpGaD
Nandrolone decanoate—MAOA—SIDS Susceptibility Pathways—CASP3—epilepsy syndrome	6.96e-05	0.000509	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—UPB1—epilepsy syndrome	6.94e-05	0.000507	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—ATIC—epilepsy syndrome	6.94e-05	0.000507	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—NEU1—epilepsy syndrome	6.94e-05	0.000507	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—VEGFA—epilepsy syndrome	6.87e-05	0.000502	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—HSD17B4—epilepsy syndrome	6.85e-05	0.0005	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—CHRM3—epilepsy syndrome	6.79e-05	0.000496	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—KCNJ11—epilepsy syndrome	6.79e-05	0.000496	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—JUN—epilepsy syndrome	6.77e-05	0.000495	CbGpPWpGaD
Nandrolone decanoate—MAOA—SIDS Susceptibility Pathways—JUN—epilepsy syndrome	6.76e-05	0.000494	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—CASP3—epilepsy syndrome	6.71e-05	0.000491	CbGpPWpGaD
Nandrolone decanoate—AR—SIDS Susceptibility Pathways—VEGFA—epilepsy syndrome	6.7e-05	0.000489	CbGpPWpGaD
Nandrolone decanoate—AR—Androgen receptor signaling pathway—AKT1—epilepsy syndrome	6.7e-05	0.000489	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—HSD17B4—epilepsy syndrome	6.68e-05	0.000488	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—GBE1—epilepsy syndrome	6.61e-05	0.000483	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—PPP1R3C—epilepsy syndrome	6.61e-05	0.000483	CbGpPWpGaD
Nandrolone decanoate—AR—Generic Transcription Pathway—VDR—epilepsy syndrome	6.55e-05	0.000479	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—JUN—epilepsy syndrome	6.52e-05	0.000477	CbGpPWpGaD
Nandrolone decanoate—MAOA—Neuronal System—PRKCB—epilepsy syndrome	6.48e-05	0.000474	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—GBE1—epilepsy syndrome	6.45e-05	0.000471	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—PPP1R3C—epilepsy syndrome	6.45e-05	0.000471	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	6.3e-05	0.000461	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—ASAH1—epilepsy syndrome	6.22e-05	0.000454	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—ASAH1—epilepsy syndrome	6.06e-05	0.000443	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—STXBP1—epilepsy syndrome	6.05e-05	0.000442	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—epilepsy syndrome	5.92e-05	0.000432	CbGpPWpGaD
Nandrolone decanoate—MAOA—SIDS Susceptibility Pathways—VEGFA—epilepsy syndrome	5.91e-05	0.000432	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—STXBP1—epilepsy syndrome	5.9e-05	0.000431	CbGpPWpGaD
Nandrolone decanoate—AR—Generic Transcription Pathway—NR3C1—epilepsy syndrome	5.9e-05	0.000431	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—ALAD—epilepsy syndrome	5.89e-05	0.000431	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—NT5E—epilepsy syndrome	5.89e-05	0.000431	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—SRC—epilepsy syndrome	5.85e-05	0.000427	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—NT5E—epilepsy syndrome	5.75e-05	0.00042	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—ALAD—epilepsy syndrome	5.75e-05	0.00042	CbGpPWpGaD
Nandrolone decanoate—AR—SIDS Susceptibility Pathways—TNF—epilepsy syndrome	5.74e-05	0.00042	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—VEGFA—epilepsy syndrome	5.7e-05	0.000416	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—ALDH7A1—epilepsy syndrome	5.62e-05	0.000411	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—CACNA1A—epilepsy syndrome	5.62e-05	0.000411	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—ABCG2—epilepsy syndrome	5.54e-05	0.000405	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—ST3GAL3—epilepsy syndrome	5.5e-05	0.000402	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—ALDH7A1—epilepsy syndrome	5.48e-05	0.000401	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—CACNA1A—epilepsy syndrome	5.48e-05	0.000401	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—CYP2C19—epilepsy syndrome	5.39e-05	0.000394	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—ADSL—epilepsy syndrome	5.39e-05	0.000394	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—ST3GAL3—epilepsy syndrome	5.37e-05	0.000392	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—CYP11A1—epilepsy syndrome	5.36e-05	0.000392	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—GLUL—epilepsy syndrome	5.29e-05	0.000386	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—ADSL—epilepsy syndrome	5.26e-05	0.000384	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—CACNA1D—epilepsy syndrome	5.19e-05	0.000379	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—GLUL—epilepsy syndrome	5.16e-05	0.000377	CbGpPWpGaD
Nandrolone decanoate—MAOA—SIDS Susceptibility Pathways—TNF—epilepsy syndrome	5.06e-05	0.00037	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—CACNA1D—epilepsy syndrome	5.06e-05	0.00037	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—EIF2S1—epilepsy syndrome	4.93e-05	0.000361	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—TNF—epilepsy syndrome	4.88e-05	0.000357	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—TXNRD1—epilepsy syndrome	4.85e-05	0.000355	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—CYP2D6—epilepsy syndrome	4.84e-05	0.000354	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—HSPB1—epilepsy syndrome	4.76e-05	0.000348	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—TXNRD1—epilepsy syndrome	4.73e-05	0.000346	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—AQP1—epilepsy syndrome	4.71e-05	0.000344	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—ADRA2A—epilepsy syndrome	4.61e-05	0.000337	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—AQP1—epilepsy syndrome	4.6e-05	0.000336	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—BCHE—epilepsy syndrome	4.59e-05	0.000335	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	4.41e-05	0.000323	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—AKT1—epilepsy syndrome	4.39e-05	0.000321	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—SLC2A1—epilepsy syndrome	4.38e-05	0.00032	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—PLCB1—epilepsy syndrome	4.33e-05	0.000316	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—TH—epilepsy syndrome	4.31e-05	0.000315	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—CHRM3—epilepsy syndrome	4.26e-05	0.000311	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—KCNJ11—epilepsy syndrome	4.26e-05	0.000311	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—KCNJ11—epilepsy syndrome	4.16e-05	0.000304	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—CHRM3—epilepsy syndrome	4.16e-05	0.000304	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—JUNB—epilepsy syndrome	3.97e-05	0.00029	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	3.87e-05	0.000283	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	3.79e-05	0.000277	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—AKT1—epilepsy syndrome	3.77e-05	0.000276	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—AKT1—epilepsy syndrome	3.63e-05	0.000266	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—HMOX1—epilepsy syndrome	3.6e-05	0.000263	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—CAT—epilepsy syndrome	3.55e-05	0.00026	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—ABCG2—epilepsy syndrome	3.47e-05	0.000254	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—ABCB1—epilepsy syndrome	3.45e-05	0.000252	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—ABCG2—epilepsy syndrome	3.39e-05	0.000248	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—CYP2C19—epilepsy syndrome	3.38e-05	0.000247	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—CYP11A1—epilepsy syndrome	3.36e-05	0.000246	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—CYP2C19—epilepsy syndrome	3.3e-05	0.000241	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—CYP11A1—epilepsy syndrome	3.28e-05	0.00024	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	3.26e-05	0.000238	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—GPX1—epilepsy syndrome	3.21e-05	0.000235	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—SIRT1—epilepsy syndrome	3.2e-05	0.000234	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—VDR—epilepsy syndrome	3.15e-05	0.00023	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—CYP2D6—epilepsy syndrome	3.04e-05	0.000222	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—H2AFX—epilepsy syndrome	2.99e-05	0.000218	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	2.97e-05	0.000217	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—CYP2D6—epilepsy syndrome	2.96e-05	0.000216	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—ADRA2A—epilepsy syndrome	2.89e-05	0.000211	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—YWHAZ—epilepsy syndrome	2.88e-05	0.000211	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—BCHE—epilepsy syndrome	2.88e-05	0.00021	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—NR3C1—epilepsy syndrome	2.84e-05	0.000207	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—ADRA2A—epilepsy syndrome	2.82e-05	0.000206	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—AGT—epilepsy syndrome	2.82e-05	0.000206	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—BCHE—epilepsy syndrome	2.81e-05	0.000205	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—APOE—epilepsy syndrome	2.76e-05	0.000202	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—SLC2A1—epilepsy syndrome	2.75e-05	0.000201	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—PLCB1—epilepsy syndrome	2.72e-05	0.000198	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—TH—epilepsy syndrome	2.71e-05	0.000198	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—SLC2A1—epilepsy syndrome	2.68e-05	0.000196	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—PLCB1—epilepsy syndrome	2.65e-05	0.000194	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—TH—epilepsy syndrome	2.64e-05	0.000193	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	2.6e-05	0.00019	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—POMC—epilepsy syndrome	2.37e-05	0.000173	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—HMOX1—epilepsy syndrome	2.26e-05	0.000165	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—CAT—epilepsy syndrome	2.23e-05	0.000163	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—HMOX1—epilepsy syndrome	2.2e-05	0.000161	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—CAT—epilepsy syndrome	2.17e-05	0.000159	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—ABCB1—epilepsy syndrome	2.17e-05	0.000158	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—ALB—epilepsy syndrome	2.16e-05	0.000158	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—ABCB1—epilepsy syndrome	2.11e-05	0.000155	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—GPX1—epilepsy syndrome	2.02e-05	0.000147	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—GPX1—epilepsy syndrome	1.97e-05	0.000144	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—PTGS2—epilepsy syndrome	1.89e-05	0.000138	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—AGT—epilepsy syndrome	1.77e-05	0.000129	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—APOE—epilepsy syndrome	1.73e-05	0.000127	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—AGT—epilepsy syndrome	1.72e-05	0.000126	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—APOE—epilepsy syndrome	1.69e-05	0.000123	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—POMC—epilepsy syndrome	1.49e-05	0.000109	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—POMC—epilepsy syndrome	1.45e-05	0.000106	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—ALB—epilepsy syndrome	1.36e-05	9.91e-05	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—ALB—epilepsy syndrome	1.32e-05	9.67e-05	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—PTGS2—epilepsy syndrome	1.19e-05	8.67e-05	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—PTGS2—epilepsy syndrome	1.16e-05	8.46e-05	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—AKT1—epilepsy syndrome	9.5e-06	6.94e-05	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—AKT1—epilepsy syndrome	8.69e-06	6.35e-05	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—AKT1—epilepsy syndrome	5.96e-06	4.36e-05	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—AKT1—epilepsy syndrome	5.82e-06	4.25e-05	CbGpPWpGaD
